GT
38
-3
MDLZ
36
-2
HCA
66
2
FIS
63
-4
MAS
54
-4
ISRG
66
-3
GPC
53
-4
AMT
36
-2
AAP
18
-15
NWSA
66
4
GS
76
3
CVS
37
5
HP
48
2
FTI
69
5
APA
57
-2
DLTR
62
-2
AZO
38
-8
BMY
64
-5
HPQ
46
2
HRL
36
-2
GT
38
-3
MDLZ
36
-2
HCA
66
2
FIS
63
-4
MAS
54
-4
ISRG
66
-3
GPC
53
-4
AMT
36
-2
AAP
18
-15
NWSA
66
4
GS
76
3
CVS
37
5
HP
48
2
FTI
69
5
APA
57
-2
DLTR
62
-2
AZO
38
-8
BMY
64
-5
HPQ
46
2
HRL
36
-2
Financhill
Back

Diebold Nixdorf, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy
76

DBD
Diebold Nixdorf, Inc.

Last Price:
$67.11
Seasonality Move:
11.65%
Buy
67

GPCR
Structure Therapeutics, Inc.

Last Price:
$68.85
Seasonality Move:
-31.39%
Buy
76
Diebold Nixdorf, Inc. (DBD) is a Buy

Is Diebold Nixdorf, Inc. a Buy, Sell or Hold?

  • The current Diebold Nixdorf, Inc. [DBD] share price is $65.60. The Score for DBD is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • DBD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $66.74. The Score for GPCR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DBD Stock Price Chart

What is Diebold Nixdorf, Inc.'s stock price today?

  • The Diebold Nixdorf, Inc. share price today is $65.60
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DBD is experiencing selling pressure, which indicates risk of future bearish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $66.74
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.

DBD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.32 Buy
Relative Strength Index (14 RSI): 59.37 Buy
Chaikin Money Flow: -339468 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.65 - 66.13) Buy
Bollinger Bands (100): (56.97 - 63.13) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.4 Buy
Relative Strength Index (14 RSI): 80.52 Buy
Chaikin Money Flow: -2951117 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.79 - 46.45) Buy
Bollinger Bands (100): (17.61 - 35.19) Buy

DBD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.35 Buy
20-day SMA: 64.13 Buy
50-day SMA: 60.72 Buy
200-day SMA: 53.81 Buy
8-day EMA: 65.13 Buy
20-day EMA: 63.97 Buy
50-day EMA: 61.85 Buy
200-day EMA: 55.23 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.28 Buy
20-day SMA: 38.08 Buy
50-day SMA: 32.93 Buy
200-day SMA: 23.94 Buy
8-day EMA: 47.33 Buy
20-day EMA: 39.93 Buy
50-day EMA: 33.93 Buy
200-day EMA: 27.69 Buy

Diebold Nixdorf, Inc. Earnings Growth & DBD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.89 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.14 per share.

Diebold Nixdorf, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):